Thomas DesRosier

Thomas DesRosier discloses dealings in Seres Therapeutics, Inc. to SEC (Form 4). The record holds 14 filings, for trades running from 5 July 2022 to 17 August 2026.

On the market, this insider has only sold: 1 sale, €322 in total. Other entries cover 1 share grant and 12 option exercises. 2026 to date brings no purchases and 1 sale.

On 18 August 2026 came the latest disclosure, an option exercise in Seres Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.